Accuray Incorporated (ARAY) vs Grace Therapeutics, Inc. (GRCE)

A side-by-side comparison of Accuray Incorporated and Grace Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Accuray Incorporated logo
ARAY
Accuray Incorporated
$33M
$0.28HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Grace Therapeutics, Inc. logo
GRCE
Grace Therapeutics, Inc.
$34M
$2.11HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT

Total return — ARAY vs GRCE

growth of $100 · dividends reinvested · last 2y
ARAY -83.2% (-59.1%/yr)GRCE -31.6% (-17.3%/yr)GRCE compounded faster over this window
050100150Start $10020252026$17$68
ARAY GRCE

ARAY vs GRCE: by the numbers

  • •GRCE is the larger company ($34M vs $33M market cap).
  • •Both run net losses; GRCE's is the smaller (0.00% vs -12.24% net margin).

Metrics side by side

Valuation

MetricARAYGRCE
P/S ratio0.08N/A
P/B ratio0.800.71

Profitability

MetricARAYGRCE
Gross margin27.73%0.00%
Operating margin-6.58%0.00%
Net margin-12.24%0.00%
ROE-117.97%-44.50%
ROIC-10.09%-52.61%

Growth (annualized)

MetricARAYGRCE
Revenue CAGR (5Y)0.28%N/A
Total return CAGR (5Y)-39.94%N/A

Go deeper

Full ARAY analysisFull GRCE analysisInteractive comparison tool

Dig into the metrics

Accuray ROEGrace Therapeutics ROEAccuray operating marginGrace Therapeutics operating marginAccuray revenue growthGrace Therapeutics revenue growthAccuray free cash flowGrace Therapeutics free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.